1139879-57-4Relevant articles and documents
Discovery of a potent, orally bioavailable pyrimidine VLA-4 antagonist effective in a sheep asthma model
Semko, Christopher M.,Chen, Linda,Dressen, Darren B.,Dreyer, Mark L.,Dunn, Whitney,Farouz, Francine S.,Freedman, Stephen B.,Holsztynska, Elizabeth J.,Jefferies, Michael,Konradi, Andrei W.,Liao, Anna,Lugar, Judevin,Mutter, Linda,Pleiss, Michael A.,Quinn, Kevin P.,Thompson, Thomas,Thorsett, Eugene D.,Vandevert, Christopher,Xu, Ying-Zi,Yednock, Ted A.
scheme or table, p. 1741 - 1743 (2011/05/04)
A series of N-(pyrimidin-4-yl)-phenylalanine VLA-4 antagonists is described. Optimization of substituents at the 2 and 5 positions of the pyrimidine ring gave 14, a very potent VLA-4 inhibitor which is orally active in a sheep asthma model.